head of the Sanofi Pasteur vaccines division at the French drugmaker. "Welcoming Origimm within Sanofi expands our area of expertise by bringing extensive know-how in the field of skin microbiome ...

The investment builds on Sanofi's alliance with mRNA specialist Translate Bio, which has already advanced vaccines for COVID-19 and seasonal influenza into clinical trials. mRNA vaccines work by ...

Climate change and mosquitos are creating an epidemic of dengue in Oaxaca, as researchers work to counteract the disease.

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

The Food and Drug Administration has cleared Novavax to move forward with testing of a combination vaccine for COVID-19 and ...

HOUSTON — Seasonal flu vaccines are now available at select UT Physicians clinics. Protection against the flu is critical as the Centers for Disease Control and Prevention estimates that 9 ...

Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...

Novavax has received the green light from the US Food and Drug Administration (FDA) to resume clinical trials for its ...

All participants were ages 5 years and older and intended to receive both flu and mRNA COVID-19 vaccines. The average age of participants was 33.4 years, and 63% were female.

“We know that there has been some instability in the supply of flu vaccines in the private market,” Lee told lawmakers. “As to whether our strategic purchasing office should count in the ...

The first influenza vaccine was a monovalent live-attenuated vaccine, which was used in Russia until recently. In 1940, a second strain of influenza virus was isolated; this was named influenza B ...